Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

CDC's Deputy Secretary General Steps Down Just 2.5 Months Into the Job

TUESDAY, Feb. 24, 2026 Leadership uncertainty at the U.S. Centers for Disease Control and Prevention (CDC) deepened this week after the agency s second-in-comma

Study Suggests Cutting Sugar Before Age 2 Could Lower Heart Disease Risk

TUESDAY, Feb. 24, 2026 Cookies, cupcakes, fruit snacks, juice boxes, oh my These sweet treats are often part of childhood. But when it comes to babies and toddl

New FDA Proposal Aims to Help Patients With Hard-to-Treat Diseases

TUESDAY, Feb. 24, 2026 U.S. health officials are proposing a new way to develop and approve custom-made treatments for people with rare and hard-to-treat condit

Plant-Based Diets May Aid Symptoms of Psoriasis

Consuming a greater proportion of nutrients from plant sources may aid management of psoriasis symptoms, according to a study published online Feb. 19 in the Eu

In Utero Exposure to Forever Chemicals Higher Than Previously Thought

Infants are exposed to a wider range of per- and polyfluoroalkyl substances (PFAS) before birth than previously thought, according to a study published online F

Obstructive Sleep Apnea Tied to Nearly Doubled Risk for Flu, COVID-19 in Childhood

Children with obstructive sleep apnea (OSA) are nearly twice as likely to contract the flu or COVID-19, according to a study published online Feb. 11 in the Jou

Physical Activity May Reduce Risk for Death From Cancer

Moderate-to-vigorous physical activity (MVPA) may lower the risk for cancer mortality among cancer survivors, according to a study published online Feb. 17 in J

Geographic Variation Seen in Declines in Cervical Cancer Incidence

Declines in cervical cancer incidence among young U.S. women during the human papillomavirus (HPV) vaccination era vary by geographic region, according to a stu

Novartis Remibrutinib First Therapy to Achieve Phase III Primary Endpoint in Chronic Inducible Urticaria (CIndU)

Basel, February 18, 2026 Novartis today announced positive topline results from its pivotal Phase III RemIND trial of oral remibrutinib in chronic inducible urt

CagriSema Demonstrated 23% Weight Loss in an Open-Label Head-to-Head REDEFINE 4 Trial in People with Obesity, the Primary Endpoint Was Not Achieved

Bagsv rd, Denmark, 23 February 2026 Novo Nordisk today announced headline results from REDEFINE 4, an open-label phase 3 trial from the global REDEFINE clinical

Popular Keywords